Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Avient Corporation (AVNT) vs Citius Pharmaceuticals Inc (CTXR) Price & Performance

Avient CorporationTrade
Citius Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

Avient Corporation vs Citius Pharmaceuticals Inc — how do they compare? Avient Corporation trades at $45.37 (market cap $4.17B), while Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M). The key difference: Avient Corporation is far larger — about 208.4× Citius Pharmaceuticals Inc's market cap, and Avient Corporation pays a 2.42% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

AVNTCTXR
Market Cap
$4.17B$20.01M
Sector
TechnologyHealth
52-Week High
$45.69$1.82
52-Week Low
$27.48$0.48
Enterprise Value
$5.62B$16.23M
Dividend Yield
2.42%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Avient Corporation

Avient Corporation is a global leader in specialized and sustainable material solutions. Formed from the legacy of PolyOne and Clariant’s masterbatch business, it provides highly engineered polymer formulations, color systems, and advanced composites that enhance the performance and sustainability of products in industries like healthcare, defense, and consumer packaging.

Read more on AVNT

About Citius Pharmaceuticals Inc

Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.

Read more on CTXR